window.dotcom = window.dotcom || { cmd: [] }; window.dotcom.ads = window.dotcom.ads || { resolves: {enabled: [], getAdTag: []}, enabled: () => new Promise(r => window.dotcom.ads.resolves.enabled.push(r)), getAdTag: () => new Promise(r => window.dotcom.ads.resolves.getAdTag.push(r)) }; setTimeout(() => { if(window.dotcom.ads.resolves){ window.dotcom.ads.resolves.enabled.forEach(r => r(false)); window.dotcom.ads.resolves.getAdTag.forEach(r => r("")); window.dotcom.ads.enabled = () => new Promise(r => r(false)); window.dotcom.ads.getAdTag = () => new Promise(r => r("")); console.error("NGAS load timeout"); } }, 5000)
Skip to content
Business Daily, Business Daily, Business and science: How risky is SynBio?

Business Daily

Business Daily

Business and science: How risky is SynBio?

Up next

September 5, 2023

17 minutes

Available for over a year

For all the exciting developments in the synthetic biology industry, there are also concerns.

People can edit genes in their garages these days, so who’s regulating this space?

Plus - we’ll hear about the exciting new business models with biology at their core, including one of the first synbio businesses to trade as a public stock - Ginkgo Bioworks.

Presenter: Gareth Mitchell

Producer: Izzy Greenfield

(Image: A petri dish in a lab. Credit: Getty Images)